Uptravi 400 (Selexipag Tablet) 400mcg

Uptravi 400mcg tablets contain selexipag, a prescription medication used to treat pulmonary arterial hypertension. This oral therapy helps manage symptoms by supporting blood vessel function. Store at room temperature and keep out of reach of children. Always follow your healthcare provider's guidance.

Strength

400mcg

Pack Size

60s

Storage

Ambient

Manufacturer / TM Owner

Actelion Pharmaceuticals

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Selexipag, the active ingredient in Uptravi 400mcg tablets, is used to treat pulmonary arterial hypertension (PAH) by helping to relax and widen blood vessels in the lungs. This medication is prescribed to improve exercise capacity and reduce symptoms like shortness of breath. It is not a cure but may help manage the condition when used as directed. Patients often ask, 'what is selexipag used for' to understand its role in long-term PAH management.

Side Effects

Uptravi 400mcg tablets may help reduce symptoms such as fatigue and shortness of breath associated with pulmonary arterial hypertension. Some users report improved ability to engage in daily activities over time. Individual responses vary, and effects may take several weeks to become noticeable. Regular monitoring by a healthcare professional is recommended to assess progress.

Precautions & Warnings

Store Uptravi 400mcg tablets at room temperature, away from moisture and heat. Keep the medication in its original packaging to protect it from light. Do not use if the packaging is damaged or the tablets appear discolored. Always inform your healthcare provider about all medications and supplements you are taking before starting selexipag.

Avoid Interactions

Uptravi 400mcg may interact with other medications that affect liver enzymes, such as certain antibiotics or antifungals. Combining it with strong CYP2C8 inhibitors can increase selexipag levels in the blood. Alcohol and grapefruit products may also affect how the medication works. Discuss all current medications with your doctor to avoid potential interactions.

Frequently Asked Questions

Uptravi 400mcg tablets are prescribed to treat pulmonary arterial hypertension by helping to relax blood vessels in the lungs.

Store the tablets at room temperature, away from moisture and direct light, in the original packaging.

Always consult your healthcare provider before combining Uptravi with other medications to avoid potential interactions.

Effects may take several weeks to become noticeable, and regular monitoring by a healthcare professional is recommended.

Uptravi 400mcg helps manage symptoms but is not a cure for pulmonary arterial hypertension.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.